Comparison of the effect of DiphenCiprone alone and DiphenCiprone with intralesional injection of platelet-rich plasma in alopecia areata
Not Applicable
- Conditions
- Alopecia areata.Other alopecia areataL63.8
- Registration Number
- IRCT20200130046311N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
A patient with alopecia areata whose definitive diagnosis was made on clinical or histological basis and their involvement was severe (> 50% scalp area and less than 100%).
Positive response to test with 2% Diphen Ciprone solution
Exclusion Criteria
Patients with alopecia totalis or universalis
Receive any systemic treatment during the last 6 months
Children under 18 years
Pregnant and lactating women
Immunosuppressed patient
patient with platelet dysfunction
patient with a history of injecting steroids on the site over the past month
Fever, systemic infection and local infection at the injection site
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity alopecia tool score (SALT score). Timepoint: Trichoscopic evaluation at baseline, 3 months later, 6 months later. Method of measurement: Trichoscope.
- Secondary Outcome Measures
Name Time Method SALT score evaluation. Timepoint: Evaluation at baseline, 3 months later, 6 months later. Method of measurement: visual evaluation.